US Corporate Controller

About us

Hansa Biopharma is a fast-growing, commercial-stage biopharmaceutical company, pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with acute or complex immune disorders.

Our broad therapeutic pipeline based on the company’s proprietary IgG-cleaving enzyme technology platform has potential to address serious unmet medical needs in autoimmune diseases, gene therapy, and transplantation.

By empowering our people we move our projects forward with high speed, efficiency and scientific excellence. We strive to attract leading talent from around the world, broaden our network of partners and establish a presence in key markets around the world. There are many opportunities for highly qualified, motivated, and passionate team players to join us on our exciting journey.

Hansa Biopharma was founded in 2007, with the corporate headquarters in Lund, Sweden and has operations in other European countries and in the US. The Company has been listed on the Nasdaq First North Growth Market Stockholm from 2007 to 2015 and on the Nasdaq Stockholm since 2015.

Position summary : US Corporate Controller

The U.S. Corporate Controller will lead all accounting, financial reporting, and internal control activities for a publicly traded, commercial-stage biotechnology company currently listed on NASDAQ Stockholm, with a potential future listing on NASDAQ. . This role requires deep technical expertise in accounting standards (including working knowledge of IFRS), reporting, and complex financial instruments, as well as the ability to operate in a dynamic, growth-oriented environment. This role is critical for ensuring smooth financial and HR operations across multiple jurisdictions.

The Controller will play a critical leadership role in supporting the company’s transition to a U.S.-listed reporting framework, preparing high-quality financial disclosures, and ensuring operational readiness for a commercial launch following regulatory approval of a Biologics License Application (BLA).

This role will be based at our NYC (Manhattan) office when opened and will require the individual to be at a daily commuting distance from NYC on the hybrid schedule.

Key tasks and responsibilities
This job description outlines key responsibilities but does not include all potential tasks or duties.

Financial Reporting & Compliance

• Oversee the preparation and filing of all SEC reports, including annual 20-F filings , quarterly filings, and other required filings (e.g., 6-Ks, proxy statements).

• Ensure compliance with accounting standards, SEC regulations, and internal accounting policies.

• Lead the drafting and review of financial statements, footnotes, and MD&A disclosures.

• Manage the external audit process and serve as the primary liaison with auditors.

• Prepare monthly, quarterly, and annual financial statements and reports in accordance with U.S. and Swedish reporting standards.

• Collaborate with the global finance team to ensure accurate consolidation of U.S. financial data with the parent company’s accounts.

• Manage budgets, forecasts, and financial planning processes for the U.S. operations.

• Monitor and manage cash flow, bank reconciliations, and ensure timely payments of invoices and other liabilities.

• Ensure compliance with financial regulations, including audits, taxes, and statutory filings.

Technical Accounting

• Lead accounting for complex transactions, including:

  • Convertible debt instruments and equity-linked securities

  • Debt restructurings and financing transactions

  • Stock-based compensation

  • Revenue recognition in a commercial-stage biotech environment

• Prepare technical accounting memos and support conclusions with authoritative guidance.

Internal Controls & Compliance

• Design, implement, and maintain a robust SOX 404 internal control framework.

• Ensure effective internal controls over financial reporting and compliance with all regulatory requirements.

• Partner with internal and external auditors on control testing and remediation.

Commercial Launch Readiness

• Support financial and operational readiness for U.S. commercial launch following BLA approval.

• Establish scalable accounting processes for product revenue, gross-to-net, inventory, and distribution.

• Collaborate cross-functionally with commercial, supply chain, and legal teams.

Tax Compliance

• Coordinate preparation and filing of all federal, state, and local taxes, including payroll taxes, corporate income taxes, and sales/use taxes.

• Ensure compliance with U.S. tax laws, including understanding the implications of any international tax treaties between the U.S. and Sweden.

• Liaise with external tax advisors to manage complex tax issues and optimize tax strategies.

Leadership & Team Management & Cross-Functional Collaboration

• Work closely with the CFO and the Swedish finance and HR teams to harmonize financial and HR policies across both countries.

• Act as a liaison between the U.S. team and Swedish headquarters, ensuring smooth communication and coordination across functions.

• Build and lead a high-performing U.S.-based accounting team.

• Coordinate with international finance teams (e.g., IFRS reporting, legacy operations).

• Drive process improvements, systems implementation, and automation initiatives.

Education and experience requirements

Required

• Bachelor’s degree in Accounting, Finance, or related field.

• 12+ years of progressive accounting experience, including leadership roles.

• Prior experience as Controller or Assistant Controller in a publicly traded company.

• Deep expertise in SEC reporting and accounting standards.

• Strong experience with:

  • Convertible debt and complex financing instruments

  • Equity accounting and stock-based compensation

  • Audit management and regulatory compliance

• Proven experience implementing or operating within a SOX 404 environment.

• Demonstrated ability to operate in a fast-paced, evolving biotech, pharmaceutical or life sciences company.

Preferred / Nice to Have

• CPA (or equivalent certification) strongly preferred.

• Prior involvement in a commercial product launch .

• Experience with both IFRS and U.S. GAAP reporting environments.

• Background with international operations and multi-entity structures.

• Big Four public accounting experience (Audit or Transaction Advisory strongly preferred).

• MBA or advanced degree.

Key Competencies

• Strong technical accounting and analytical capabilities

• High attention to detail with a commitment to accuracy and integrity

• Ability to communicate complex accounting matters to senior leadership and the Board

• Proven leadership and team-building skills

• Hands-on, roll-up-your-sleeves mindset with strategic perspective

Our culture and values

Working at Hansa is more than a job for us, and our culture is characterised by pride — pride in what we do, in our company, and in what we have achieved and will accomplish for patients around the world.

Our culture is built on our core values: Accountability, Courage, Integrity, and Pioneering. These values guide how we work, collaborate, and make decisions every day.

We know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the countries and communities in which we operate and ultimately the patients we exist to serve.

Reasons to join the Hansa Team

• Opportunity to play a key leadership role in a growing, publicly traded biotech company.

• Direct impact on U.S. commercialization and corporate transformation.

• Collaborative, high-performance culture with global reach.

• A position in a company that envisions life changing outcomes for patients with acute or serious immune mediated conditions.

• The chance to be part of an innovative R&D-driven organisation with a strong desire to make a difference for people.

• An opportunity to build a fully integrated biopharmaceutical company.

• An open-minded and welcoming atmosphere. Friendly, motivated and skilled colleagues with whom you can both laugh and work.

Hansa is an equal opportunity employer that values diversity. We provide equal opportunities to all employees and applicants for employment and prohibit discrimination or harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, marital status or any other characteristic protected by federal, state or local laws.

Estimated salary range for this role is $225,000 - $250,000 annually. The actual base salary offered may depend on a variety of factors, including the qualifications, skills and experience of the individual applicant, level of education attained, certifications or other professional licenses held, and the geographic location of the individual. The actual base salary offered will be in accordance with state or local minimum wage requirements for the job location.

U.S. based employees may be eligible for short-term and/ or long-term incentives, as well as participation in medical, dental, vision insurance, a 401(k) plan and company match, short-term and long-term disability coverage, basic life insurance, company holidays and well-being benefits.

Location

Hybrid Position in NYC

The process

All applicants should apply on Hansa Biopharma’s website to be considered for employment. We do not accept unsolicited candidate introductions or referrals from third party recruiters and staffing agencies, and we are not responsible for any fees associated with unsolicited referrals.

Attach your CV in English only. Unfortunately, we are unable to review applications made in other languages.

The process is ongoing and we will review applications as they are received.

We look forward to receiving your application – join us and make significant contributions to Hansa Biopharma´s research!

Please note: No external recruitment support is required. Only applications received directly will be considered.